Active Ingredient(s):Pegfilgrastim-apgf FDA Approved: * June 10, 2020 Pharm Company: *HOSPIRA INC Category:Cancer
Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils). Pegfilgrastim was developed by Amgen.
Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemo...
* May have multiple approval dates, manufacturers, or labelers.